Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 804 questions Show Answers
To ask the Scottish Government whether it plans to review the affordability threshold for connections delivered through the R100 Scottish Broadband Voucher Scheme, which currently stands at £56 per month.
To ask the Scottish Government whether it will consider strengthening provisions within the Housing (Scotland) Bill to support prospective tenants in addition to those with existing tenancies.
To ask the Scottish Government whether it will provide an update on the roll-out of the R100 programme in Dumfries and Galloway.
To ask the Scottish Government how many approved providers are available to provide superfast service via the R100 Scottish Broadband Voucher Scheme in the Mid Galloway and Wigtown West council ward in Dumfries and Galloway.
To ask the Scottish Government how many properties are still to be connected in Dumfries and Galloway under the R100 programme.
To ask the Scottish Government how many applications for the R100 Scottish Broadband Voucher Scheme have been (a) successful and (b) unsuccessful across Dumfries and Galloway.
To ask the Scottish Government, following the Parliament's agreement of the Scottish Budget in each of the last five years, on what date NHS boards (a) were advised of their individual budget allocations and (b) received their settlement for the next year.
To ask the Scottish Government whether the increase in the National Living Wage from 1 April 2024 will result in an uplift for the Community Pharmacy Scotland financial settlement from the same date.
To ask the Scottish Government whether it will provide an update on what plans it has to clarify additional measurements for monitoring improvements in (a) blood and (b) neurological cancer pathways.